Cardinal Health Inc. 8-K Summary
Business Context and Reporting Period
Cardinal Health, Inc. filed a Current Report on Form 8-K on October 8, 2024, regarding the entry into material definitive agreements related to its corporate credit facilities and commercial paper program.
Key Financial Metrics and Agreements
- Revolving Credit Facility: Entered into a 364-Day Credit Agreement providing access to $1.0 billion in revolving credit, terminating on October 7, 2025.
- Commercial Paper Program: Increased the maximum principal amount of outstanding commercial paper notes from $2.0 billion to $3.0 billion.
- Financial Covenant: The Credit Agreement requires a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00 as of the last day of any fiscal quarter.
- Interest Rates: Borrowings are benchmarked based on Term SOFR and subject to the Company's credit ratings.
- Usage: The facility is for general corporate purposes and backs the commercial paper program.
Material Changes
The primary material change is the expansion of liquidity capacity through the new credit agreement and the amendment to the commercial paper program. The filing does not provide comparative financial performance data (revenue, profit, cash flow) as this is a transactional filing rather than a periodic financial report.
Outlook, Risks, and Contingencies
- Conversion Option: The Company may elect to convert outstanding principal on the termination date into non-revolving term loans repayable one year later.
- Covenants: The agreement includes customary affirmative and negative covenants, including restrictions on incurring liens, subsidiary indebtedness, and contingent obligations.
- Events of Default: Includes non-payment of principal or interest and breaches of covenants, which could lead to acceleration of loans and termination of commitments.
Investor Verification Checklist
- Verify the full terms of the 364-Day Credit Agreement filed as Exhibit 10.1.
- Confirm the current Consolidated Net Leverage Ratio to ensure compliance with the 3.75 to 1.00 covenant.
- Review the specific conditions required to convert revolving loans into term loans.
- Monitor the Company's credit rating, as it directly impacts interest rates under the new facility.